Pirouette aims to revolutionize the $600 billion injectable drug market with its patented technology, making life-saving injections available at the push of a button.
Portsmouth, New Hampshire, May 7, 2024–(BUSINESS WIRE)–Pirouette, the innovative auto-injector platform, announces more than $5 million in community investment round on Wefunder and extends round due to overwhelming demand It happened. This enhancement gives millions of people access to this solution designed to increase their time to investment and accelerate their path to availability. This is a unique opportunity to join renowned institutional investors such as Safar Partners, Liquid 2 Ventures and Gainels.
Pirouette, led by a team of rocket scientists from MIT, Harvard Medical School, Harvard Business School, Clarkson University, General Electric, and NASA, simplifies life-saving injections such as epinephrine for severe allergies and naloxone for opioid overdoses. , is about to revolutionize drug management. . With 21 patents granted and additional filings underway, this investment round has captured the attention of industry leaders and investors, recognizing Pirouette’s potential to disrupt the dinosaur injectable industry. The company’s mission to simplify injectable treatments aligns with the growing demand for patient-centered healthcare solutions. 93% of surveyed patients and 70% of surveyed prescribers would like to switch to Pirouette’s patented epinephrine auto-injector once it is approved and available.
Dr. Conor Cullinan, CEO and co-founder of Pirouette Medical, said: “With severe allergies on the rise and the opioid crisis growing, which affects everyone, the need for our innovative auto-injectors has never been greater.”
Matthew Cain, chief operating officer of Pirouette Medical “This is an important step towards bringing our ground-breaking equipment to market.”
Pirouette’s investment round is open to the public for a limited time through Wefunder, the leading platform for early-stage personal investing, and anyone who is affected or has a loved one who will be affected is encouraged to invest in Pirouette and raise their shares. You have the opportunity to own one. company.
To learn more about Pirouette Medical and join Rethinking Injections, visit wefunder.com/pirouette. Investments start at $100 and can go up to $500,000 or more.
About Pirouette Medical:
Pirouette Medical is committed to revolutionizing the medical industry with innovative auto-injector technology that delivers life-saving injections with the push of a button. Founded by experts from MIT, HMS, HBS, and Clarkson University, Pirouette aims to transform the $600 billion injectable drug market. Backed by Y Combinator, Safar Partners, Liquid 2 Ventures, and Gainels, he has been awarded 21 patents. Pirouette is dedicated to making important treatments more accessible and less fearful for patients. Masu.
View source version on businesswire.com. https://www.businesswire.com/news/home/20240507871732/ja/
contact address
nina ekmesic
Nina@capitaldept.com
6023448725
